2 withdrawn, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 2, Unknown 1 |
Follow Organ Transplant Recipients: new trials by email Literature Review of Organ Transplant Recipients trials Research Report on Organ Transplant Recipients
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Immunotherapy, Cutaneous Squamous Cell Carcinoma | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2025-05-07 | |
| Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Cutaneous Squamous Cell Carcinoma, Actinic Keratoses | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2025-05-07 | |
| Phase II AK Study in Organ Transplant Patients Afamelanotide (CUV1647), Placebo - Actinic Keratoses, Carcinoma, Squamous Cell | Phase 2 | Unknown | Clinuvel Pharmaceuticals Limited | 200 | 2007-11-01 | 2010-12-06 |
Carcinoma, Squamous Cell (3) · Keratosis, Actinic (3) · Skin Neoplasms (2)
Carcinoma (3) · Keratosis (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Squamous Cell (3) · Precancerous Conditions (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Neoplasms by Site (2)
Fluorouracil (2) · Petrolatum (2) · afamelanotide (1)
Massachusetts General Hospital (2) · Clinuvel Pharmaceuticals Limited (1)
United States (2) · Australia (1) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Sweden (1) · Switzerland (1)